The Globe and Mail reports in its Wednesday edition that Canaccord Genuity analyst Katie Lachappelle has elevated her recommendation for EnCore Energy to "buy" from "speculative buy" with an $8 share target, up from $7. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $7.76. Ms. Lachappelle says in a note: "EnCore Energy is one of our preferred ways to play the uranium space. Within a matter of weeks, the company will have two operating mines in Texas. The Rosita plant commenced production in November, 2023, and the Alta Mesa project is on track to start production in late April or early May. We project 450,000lbs U3O8 of production from Rosita, and 400,000lbs from Alta Mesa in 2024. The profitability of these operations is well protected, in our view. EnCore has implemented a sales strategy focused on securing a base level of projected income via established offtakes, while also preserving the potential for exposure to the spot market through uncommitted production. To date, EnCore has signed five utility contracts totalling 4.25mlb U3O8, beginning in 2024 and extending through to 2032 (covering less than 50 per cent of EnCore's planned production)."